Form 8-K ICAD INC For: Oct 18

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 18, 2016

 

 

iCAD, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware		1-9341		02-0377419
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

98 Spit Brook Road, Suite 100

Nashua, NH 03062

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (603) 882-5200

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 18, 2016, iCAD, Inc. (the “Company”) granted restricted shares of Company common stock (the “Restricted Shares”) to Kenneth Ferry and Stacey Stevens. Mr. Ferry received 75,000 Restricted Shares that will vest in equal quantities over a three year period from the grant date of such shares. Mr. Ferry also received 75,000 Restricted Shares that will vest in accordance with performance criteria based on revenue growth. Ms. Stevens received 37,500 Restricted Shares that will vest in equal quantities over a three year period from the grant date and 37,500 Restricted Shares that vest in accordance with performance criteria based on revenue growth.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

				iCAD, INC.
Dated: October 21, 2016				/s/ Kenneth Ferry
				Kenneth Ferry
				Chief Executive Officer

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Medigene AG reports Financial Results and Business Update for Q1 2024
• Flash News: OKX Wallet Now Supports Reading of Staked STONE
• Agronomics Limited Announces Solar Foods Raises an Additional EUR8 Million